The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.


Updates from The Motley Fool

Latest updates on Sangamo Biosciences from Fool.com.
Why Did My Stock Just Die?

Only those whistling past the graveyard had to expect Greece to live up to its austerity measures...



Stock Performance

View Interactive SGMO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sangamo Biosciences.
Current Price: $3.10
Prev Close: $3.05
Open: $3.05
Bid: $3.05
Ask: $3.20
Day's Range: $2.90 - $3.25
52wk Range: $2.90 - $9.91
Volume: 1,023,533
Avg Vol 868,506
Market Cap: $217M
P/E (ttm): -2.82
EPS (ttm): ($1.08)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sangamo Biosciences.
CAPS Rating 4 out of 5
 
267 Outperform
16 Underperform
CAPS All Stars
 
52 Outperform
5 Underperform

How do you think Sangamo Biosciences will perform against the market?



You pick for Sangamo Biosciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Sandy Macrae, M.B., Ch.B., Ph.D., CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sangamo Biosciences.

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers